Salarius Pharmaceuticals Ord Shs
DCOY0.820USD
+0.050+6.47%
Close 01/09, 16:00（ET）Quotes delayed by 15 min
--Market Cap
--P/E TTM
More Details of Company
Salarius Pharmaceuticals Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Salarius Pharmaceuticals Ord Shs
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Name
Name/Position
Position
Shareholding
Change
,
,
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Jan 9
Updated: Fri, Jan 9
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Heights Capital Management, Inc.
5.12%
Rosenblum (Mark J)
0.34%
Pierce (Frederick E)
0.28%
Other
94.25%
Shareholders
Shareholders
Proportion
Heights Capital Management, Inc.
5.12%
Rosenblum (Mark J)
0.34%
Pierce (Frederick E)
0.28%
Other
94.25%
Shareholder Types
Shareholders
Proportion
Investment Advisor
5.13%
Individual Investor
0.64%
Other
94.23%
Institutional Shareholding
Updated: Fri, Jan 9
Updated: Fri, Jan 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
21
300.93K
5.13%
+290.06K
2025Q4
23
300.93K
5.13%
+289.60K
2025Q3
22
938.00
0.08%
-10.40K
2025Q2
21
8.13K
5.74%
+1.26K
2025Q1
16
4.66K
4.00%
+958.00
2024Q4
17
1.38K
1.44%
-1.30K
2024Q3
27
349.00
0.36%
-3.44K
2024Q2
28
1.74K
4.37%
-1.13K
2024Q1
34
1.60K
4.46%
-1.52K
2023Q4
41
4.17K
17.26%
-104.00
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Heights Capital Management, Inc.
300.00K
5.12%
+300.00K
--
Nov 12, 2025
Rosenblum (Mark J)
20.18K
0.34%
+20.00K
+10989.01%
Nov 20, 2025
Pierce (Frederick E)
16.67K
0.28%
+16.67K
--
Nov 12, 2025
Advisory Services Network, LLC
500.00
0.01%
+500.00
--
Sep 30, 2025
Arthur (David J)
409.00
0.01%
--
--
Oct 24, 2025
Horizon Kinetics LLC
249.00
0%
--
--
Dec 31, 2025
The Vanguard Group, Inc.
83.00
0%
--
--
Nov 30, 2025
Osaic Holdings, Inc.
62.00
0%
+58.00
+1450.00%
Sep 30, 2025
UBS Financial Services, Inc.
29.00
0%
-1.18K
-97.60%
Sep 30, 2025
Lieber (Jonathan I)
25.00
0%
--
--
Oct 24, 2025
View more
Related ETFs
Updated: Fri, Jan 9
Updated: Fri, Jan 9
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Salarius Pharmaceuticals Ord Shs?
The top five shareholders of Salarius Pharmaceuticals Ord Shs are:
Heights Capital Management, Inc. holds 300.00K shares, accounting for 5.12% of the total shares.
Rosenblum (Mark J) holds 20.18K shares, accounting for 0.34% of the total shares.
Pierce (Frederick E) holds 16.67K shares, accounting for 0.28% of the total shares.
Advisory Services Network, LLC holds 500.00 shares, accounting for 0.01% of the total shares.
Arthur (David J) holds 409.00 shares, accounting for 0.01% of the total shares.
Heights Capital Management, Inc. holds 300.00K shares, accounting for 5.12% of the total shares.
Rosenblum (Mark J) holds 20.18K shares, accounting for 0.34% of the total shares.
Pierce (Frederick E) holds 16.67K shares, accounting for 0.28% of the total shares.
Advisory Services Network, LLC holds 500.00 shares, accounting for 0.01% of the total shares.
Arthur (David J) holds 409.00 shares, accounting for 0.01% of the total shares.
What are the top three shareholder types of Salarius Pharmaceuticals Ord Shs?
The top three shareholder types of Salarius Pharmaceuticals Ord Shs are:
Heights Capital Management, Inc.
Rosenblum (Mark J)
Pierce (Frederick E)
Heights Capital Management, Inc.
Rosenblum (Mark J)
Pierce (Frederick E)
How many institutions hold shares of Salarius Pharmaceuticals Ord Shs (DCOY)?
As of 2026Q1, 21 institutions hold shares of Salarius Pharmaceuticals Ord Shs, with a combined market value of approximately 300.93K, accounting for 5.13% of the total shares. Compared to 2025Q4, institutional shareholding has increased by --.
What is the biggest source of revenue for Salarius Pharmaceuticals Ord Shs?
In --, the -- business generated the highest revenue for Salarius Pharmaceuticals Ord Shs, amounting to -- and accounting for --% of total revenue.
